# DeepThink PTB

> Precision intelligence platform for oncologists to interpret tumor data and guide therapy. (iPhone/iPad app by Deepthink Health, Inc.)

- Source: https://appshunter.io/ios/app/deepthink-ptb/id1484368681 (this page in markdown: same URL + `.md`)
- Developer: [Deepthink Health, Inc](https://appshunter.io/developer/1484368680)
- Category: Medical
- Price: Free
- Rating: 5.00/5 from 4 App Store ratings
- Age rating: 17+
- Requires: iOS 9.2 · 34 MB
- Languages: English
- Released: 2019-11-27
- Data updated: 2026-06-09
- Monetization: free
- User reviews in markdown: https://appshunter.io/ios/app/deepthink-ptb/id1484368681/reviews.md

## What is DeepThink PTB?

DeepThink Health Precision Tumor Board ™
Advancing medicine with precision intelligence ™
 
DeepThink Health has developed an innovative precision intelligence platform which captures and structures large clinical and genomic datasets, and then applies our advanced analytics and machine learning to enable precision medicine. Just as in the desktop Precision Tumor Board application, in our mobile app we’ve integrated and processed a cancer patient’s molecular/genomic tumor report enabling Molecular Tumor Board and Standard Tumor Board to quickly interpret the complex data for oncologists urgently needing to prescribe the right therapies for their cancer patients.  Tumor Board members can:
•	Quickly see FDA approved therapies with predictive responses for the patient’s specific tumor type and genetic characteristics
•	Easily select among targeted therapies based on biomarkers or suggest therapies to enhance the molecular report interpretation
•	See clinical trials already screened for the patient case in context
•	Collaborate with other Molecular Tumor Board members to quickly and timely provide a succinct report to the treating oncologist
•	Schedule and hold virtual tumor board meeting
•	No private health information is stored or relayed in the application, DeepThink Health products are HIPAA compliant. 



About DeepThink Health
DeepThink Health has developed an innovative precision intelligence platform which captures and structures large clinical and genomic datasets, and then applies our advanced analytics and machine learning to enable precision medicine. Our team has extensive experience and success in leading Healthcare IT companies serving providers, payers and pharmacies. Our Precision Analytics and Precision Intelligence solutions have been successfully implemented at large Healthcare IDNs where the combined genomic, clinical and outcome data were analyzed using DeepThink Artificial Intelligence tools to advance precision medicine and enable novel discoveries.

## Key features

- Interpret genomic tumor reports
- Identify FDA-approved therapies
- Suggest targeted therapies
- Screen clinical trials
- Collaborate with tumor board members
- Schedule virtual meetings


## Frequently asked questions about DeepThink PTB

### What is DeepThink PTB used for?

DeepThink PTB is a precision intelligence platform designed to help oncologists interpret complex genomic tumor data. It assists in identifying FDA-approved therapies, suggesting targeted treatments, and screening relevant clinical trials for cancer patients.

### Who developed DeepThink PTB?

DeepThink PTB was developed by Deepthink Health, Inc., a company focused on advancing medicine with precision intelligence through innovative platforms.

### Is DeepThink PTB available on Android devices?

Based on the provided information, DeepThink PTB is currently supported on iPhone and iPod devices. Compatibility with Android devices is not specified.

### How often is DeepThink PTB updated?

The latest version of DeepThink PTB is 2.02, and it was last updated on June 25, 2022. This indicates a release cycle that may vary, but updates are provided to enhance the platform.

### Does DeepThink PTB store private health information?

No, DeepThink PTB does not store or relay private health information within the application. The platform is designed to be HIPAA compliant, ensuring patient data privacy and security.

### What is the age rating for DeepThink PTB?

DeepThink PTB has an age rating of 17+, suggesting it is intended for mature users due to the complex medical information and professional context it addresses.

### What are the benefits of using DeepThink PTB for oncologists?

Oncologists can quickly interpret complex tumor data, identify relevant FDA-approved therapies and clinical trials, and collaborate with other tumor board members to provide timely and precise treatment reports.

### Does DeepThink PTB have ads?

No, DeepThink PTB does not contain advertisements. The application is free to use and does not display any ads, ensuring a focused user experience.

## Version history (last 5 releases)

### 2.02 — 2022-06-25

1) Add Standard Tumor Board
2) Add virtual meetings

### 1.20 — 2020-07-07

Fix for manually added drug related to biomarker

### 1.1.0 — 2020-04-11

1) Workflow improvement
2) Manually add treatment drugs

### 1.0.9 — 2020-02-10

1) users are able to add drug with biomarker.
2) patient list filter improvement.

### 1.0.8 — 2020-01-29

Enable users to add drugs and biomarkers

## Apps similar to DeepThink PTB

| App | Rating | Price | Category |
| --- | --- | --- | --- |
| [Skin Therapy Letter](https://appshunter.io/ios/app/skin-therapy-letter/id398648893) | 1.0 (1) | Free | Medical |
| [Tryal AI](https://appshunter.io/ios/app/tryal-ai/id6749471076) | 5.0 (6) | Free | Medical |
| [Medeligo](https://appshunter.io/ios/app/medeligo/id1000247107) | 5.0 (9) | Free | Medical |
| [epiLife](https://appshunter.io/ios/app/epilife/id1641271314) | — | Free | Medical |
| [GenomeOne](https://appshunter.io/ios/app/genomeone/id6466174872) | — | Free | Medical |
| [Medocity Clinical Trials](https://appshunter.io/ios/app/medocity-clinical-trials/id1093145900) | — | Free | Medical |

---

*Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-06-09.*
